Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-01, Stock:PFE, The news for the past five days is as follows:
2020-11-23: NEWS1: Too Early to Call BioNTech the Winner in the COVID-19 Vaccine Race, Says Analyst.NEWS2: Oil up on Vaccine Positivity, U.S. Electoral Transition Certainty.NEWS3: Oil Stocks Are Finally Bouncing Back.NEWS4: Asian Stocks Up Over Progress on Biden Transition, COVID-19 Vaccine.NEWS5: Fears of a COVID-inspired crude oil glut? Fading ‘contango’ tells a different story.NEWS6: AstraZeneca Dives On Covid Vaccine News, Buoying Moderna, BioNTech.NEWS7: BNP Paribas' Mark Howard on his 2021 market outlook.NEWS8: 'We still have a major problem with outpatient testing': Dr. Amesh Adalja.NEWS9: Doctor: ‘It’s probably going to be springtime’ before general public gets COVID-19 vaccine.NEWS10: A successful Ebola vaccine delivery shows how a Covid-19 vaccine would work in Africa.NEWS11: How Good Is AstraZeneca's Vaccine News?.NEWS12: AstraZeneca Shares Dip Over 3% After COVID-19 Vaccine Proves 70% Effective as Against Rivals.NEWS13: Astra-Oxford Vaccine Found Effective in Preventing Covid.NEWS14: U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections.NEWS15: 3 Dividend Stocks Gurus Like.NEWS16: Regeneron Is Allowed to Sell the Covid Antibody It Served Trump and the Stock Is Rising.NEWS17: AstraZeneca, Oxford Say Cheap, Easy to Store Vaccine Is Up to 90% Effective.NEWS18: With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?.NEWS19: Dow Jones Today, Stocks Open Higher; Merck, Regeneron Jump On Covid News; Tesla Nails A Breakout.NEWS20: Moderna Chief Sells More Shares Ahead of Key Vaccine Filing.NEWS21: Here’s When the First Americans Could Get a Coronavirus Vaccine.NEWS22: Vaccines Are Coming Soon. Is It Time to Sell Stay-at-Home Stocks?.NEWS23: AstraZeneca COVID Vaccine Hits 90% Efficacy in Some Doses.NEWS24: Dow Jones Today Leads Futures Higher, Merck Jumps Into Covid Game; Regeneron Treatment Gets FDA Nod.NEWS25: Your DIY Pandemic Projects Are Helping Home Depot (HD).NEWS26: AstraZeneca’s Tests Show a Third Effective Covid-19 Vaccine. What Happens Now?.NEWS27: Could Late-Stage Coronavirus Vaccine Trials Fail?.NEWS28: Pandemic Expert Answers: 'Do You Foresee Challenges with Vaccine Distribution?'.NEWS29: Ask A Virologist: What's The Timeline for Coronavirus Vaccine Distribution?.NEWS30: Thinking About Buying Coronavirus Vaccine Stocks? Watch This First.NEWS31: What Investors Need To Know About Companies Working on Coronavirus Vaccines.NEWS32: COVID-19 Vaccine Update – AstraZeneca Releases Trial Results.NEWS33: U.S. prepares for first COVID-19 shots as another vaccine candidate emerges.NEWS34: 2 Pick-and-Shovel COVID Vaccine Stocks to Watch.NEWS35: Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors.NEWS36: Better Buy: Gilead Sciences vs. Pfizer.NEWS37: Since Getting a 'Shot' of News, the Indexes Have Been Looking Pale.NEWS38: UK medicine regulator will make Pfizer vaccine decision in "shortest time possible".NEWS39: AstraZeneca-Oxford COVID-19 vaccine can be up to 90% effective, late-stage trials show.NEWS40: Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virus.NEWS41: AstraZeneca, Oxford Covid-19 vaccine can be up to 90% effective, late-stage trials show.NEWS42: Wall Street Analysts Say These 5 Stocks Are A Buy As The World Prepares For The Post-COVID-19 Era.NEWS43: Q&A: Where are we in the COVID-19 vaccine race?.NEWS44: Bill Gates Says AstraZeneca, Johnson & Johnson, Novavax COVID-19 Vaccines All Likely To Prove 'Very Efficacious And Safe' By February.NEWS45: AstraZeneca study finds its COVID-19 vaccine effective, with one regimen showing 90% efficacy.NEWS46: EM Review: Vaccine Optimism Powered Risk Assets to Weekly Gain.NEWS47: Gold’s Big Question: Can the Bull Market Outlive a Pandemic?.
2020-11-24: NEWS1: Three Events Markets Will Be Watching As 2020 Comes To A Close.NEWS2: Merck Sales Hit Hardest by Pandemic.NEWS3: GE Aviation Can't Hold Out For Coronavirus Vaccines, Eyes More Cuts.NEWS4: Doctor on positive COVID-19 vaccine news: 'We still need to look at all of the data'.NEWS5: Dow 30,000 Optimism Not Matched by Bond Traders.NEWS6: Coronavirus update: HHS puts vaccine distribution in states' power; Wall Street analysts project lifelong vaccine protection.NEWS7: The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer.NEWS8: 'Reflationary trends' are going to continue into 2021: Research Affiliates.NEWS9: Spread of Top-Ranked Value ETFs to Bet on Vaccine Optimism.NEWS10: Reinventing Vaccines To Save Lives And The Economy.NEWS11: Pfizer (PFE) Begins Phase III Study on Hemophilia Candidate.NEWS12: How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?.NEWS13: U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record.NEWS14: 3 Coronavirus Vaccine Makers Near Finish Line in November.NEWS15: Gold Under $1800, Overrun By Risk-on Train.NEWS16: Pfizer COVID-19 vaccine could reach Mexico in December, foreign minister says.NEWS17: Write A Prescription For This Pharma ETF.NEWS18: Be Like Buffett and Wager on Pfizer. Here’s How to Do It With Options..NEWS19: Coronavirus vaccine: AstraZeneca could expand US trial to pursue 90% efficacious vaccine.NEWS20: 5 Top-Performing Leveraged ETF Areas of Last Week.NEWS21: Coronavirus Vaccine Stocks: Is There Room For Multiple Winners?.NEWS22: Cyclical Stocks Pop on Vaccine Progress: 5 Solid Buys.NEWS23: Will Moderna's Coronavirus Vaccine Really Change the Game?.NEWS24: Why Now May Be the Time to Buy Health Care Stocks.NEWS25: Most Americans will comparison shop the coronavirus vaccine.NEWS26: What The Flu Shot's History Tells Us About Coronavirus Vaccines.NEWS27: What to Watch for Next in the Coronavirus Vaccine Race.NEWS28: What Investors Need To Know About Pfizer's Coronavirus Vaccine And Ultra-Cold Storage Requirements.NEWS29: Should Pfizer Shareholders Sell Their Viatris Stock?.NEWS30: Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine.NEWS31: Is Boris Johnson's Britain Finally Turning a Corner?.NEWS32: EU drug regulator could rule on COVID-19 vaccines by year end - report.NEWS33: StockBeat: Compass, AO World Make a Picture of the Great Rotation.NEWS34: Dollar Weakens as Biden's Transition Becomes Clearer.
2020-11-25: NEWS1: How a Restructured Pfizer Will Pay Out Its Dividend.NEWS2: How to Invest in a Post-COVID World.NEWS3: CDC may shorten coronavirus quarantine guidelines: WSJ.NEWS4: Moderna Surges Above Buy Point On European Deal For Covid Vaccine.NEWS5: Getting a COVID-19 test ahead of Thanksgiving travel is 'not as good as staying home’: Doctor.NEWS6: Moderna Soars to Record Ahead of Final Covid Vaccine Analysis.NEWS7: Pfizer Stock Moved Markets This Month, But Can it Rally?.NEWS8: Overlook Novavax at the Risk of Incurring an Opportunity Cost.NEWS9: Moderna’s Final Covid Vaccine Results Are Imminent. Billions in Revenue Will Follow, Goldman Says..NEWS10: 3 EV Stocks to Buy as the Sector Charges Up.NEWS11: Trade Zoom with Confidence After This Harsh Correction.NEWS12: It’s Time for iBio Speculators to Consider Something Else.NEWS13: Redfield: CDC will have shortened quarantine guidelines in a week.NEWS14: The Top 5 Telehealth Stocks Disrupting the Healthcare Sector.NEWS15: Hospital workers called exhausted as U.S. records highest number of COVID deaths since May.NEWS16: COVID-19 is the ‘silent pandemic’, this surge is not like last spring: Robert Redfield.NEWS17: Bears Hold an Edge Ahead of Zoom (ZM) Earnings Report.NEWS18: Coronavirus update: CDC to decrease quarantine time; UPS ramps up dry ice production.NEWS19: Should Value Investors Pick Pfizer (PFE) Stock Right Now?.NEWS20: Equillium's stock tumbles after decision to not initiate late-stage trial of COVID-19 treatment.NEWS21: Thanksgiving Brings Strong Seasonal Market Trends: 5 Picks.NEWS22: U.S. loans $1.1 billion to Ginkgo Bioworks for pandemic effort.NEWS23: Dow Hits 30K for First Time: 7 Stocks Driving the ETF Rally.NEWS24: U.S loans $1.1 bln to Ginkgo Bioworks for pandemic effort.NEWS25: Here's How the Top 3 Coronavirus Vaccine Candidates Stack Up.NEWS26: Warp Speed for Clean Energy? That Won't Work.NEWS27: Could AstraZeneca's Coronavirus Vaccine Beat Pfizer and Moderna?.NEWS28: Better Coronavirus Stock: Pfizer or Moderna?.NEWS29: EXPLAINER-When and how will COVID-19 vaccines become available?.NEWS30: 6.4M Pfizer COVID-19 Vaccine Doses To Be Distributed Across US Within 24 Hours Of FDA Approval: WaPo.
2020-11-27: NEWS1: Peru secures 23.1 million future coronavirus vaccine doses from Pfizer, COVAX.NEWS2: United Airlines starts charter flights to distribute Pfizer's COVID-19 vaccine: WSJ.NEWS3: AstraZeneca Stock Recovers From Dive On Covid Vaccine Testing Plans.NEWS4: Top Stock Reports for NVIDIA, Pfizer & Abbott.NEWS5: Stock market news live updates: Wall Street notches slim gains; Nasdaq, S&P 500 set new records.NEWS6: Gold Crashes Below $1,800.NEWS7: AstraZeneca Stock Tumbles As It Plans Additional Testing For Covid Vaccine.NEWS8: This week in Trumponomics: Grasping at stocks.NEWS9: AstraZeneca’s Vaccine Test Mistake Is a Buying Opportunity, Citi Says.NEWS10: Here's How Much Investing $1,000 In Major Coronavirus Vaccine Developers Before Their Announcements Would Fetch.NEWS11: 4 Biotechs Likely to Gain on Coronavirus Vaccine Efforts.NEWS12: Pharma Stock Roundup: AZN COVID-19 Vaccine Interim Data, PFE Emergency Use Appeal.NEWS13: U.K. Pushes for AstraZeneca Vaccine Approval Amid Questions Over Trial Data.NEWS14: 4 Consumer Discretionary Gainers From Positive Vaccine News.NEWS15: 3 Dividend Stocks Ideal for Retirees.NEWS16: Top 10 Stocks Warren Buffett Just Bought.
2020-11-30: NEWS1: Moderna Hits A Record High As It Seeks FDA OK For Coronavirus Vaccine.NEWS2: Novavax Reverses Earlier Losses As It Plans U.S. Covid Vaccine Test.NEWS3: The Zacks Analyst Blog Highlights: NVIDIA, Pfizer, Abbott, UPS and ICICI.NEWS4: Dr. Howard Forman on COVID-19 vaccine distribution: 'We must have coordination at the federal level'.NEWS5: Coronavirus update: U.S. cases slip again, but deaths are rising in 39 states and hospitalizations break another record.NEWS6: Moderna Soars on Plans to Seek Clearance for Covid Vaccine.NEWS7: Almost a third of the U.S. could be infected by the coronavirus within a month, former FDA chief warns.NEWS8: Coronavirus update: Moderna files for EUA; Novavax prepares for Phase 3.NEWS9: U.K. Could Become First Country to Roll Out Covid-19 Vaccine as Pfizer-BioNTech Approval Likely ‘Within Days’.NEWS10: Is Pfizer (PFE) A Good Stock To Buy Now?.NEWS11: Moderna (MRNA) Amends Coronavirus Vaccine Supply Deal in U.K..NEWS12: Moderna hits $58B as it files for COVID-19 vaccine emergency use.NEWS13: Moderna Stock Is Outta Sight.NEWS14: Novavax Gains After U.K. Vaccine Study Fully Enrolled.NEWS15: Gold Sinks 6% in Worst Month Since 2016.NEWS16: 5 of the Best Stocks to Buy Heading Into December.NEWS17: IPO Roadshows for Airbnb and DoorDash.NEWS18: Moderna to seek U.S. and EU authorization for its vaccine on Monday.NEWS19: Q&A: Where are we in the COVID-19 vaccine race?.

Answer: Rise